tradingkey.logo

Marker Therapeutics Inc

MRKR
1.100USD
-0.030-2.65%
Close 11/25, 16:00ETQuotes delayed by 15 min
18.37MMarket Cap
LossP/E TTM

Marker Therapeutics Inc Earnings Date

Period
FY2024 Earnings Date
Revenue(YoY)
6.59M
99.06%
EPS(YoY)
-1.20
-27.81%
Analyst Rating
BUY
2025-11-25

Financial Indicators

EPS
Revenue
Net Profit
Net Margin
Gross Margin
Debt to assets ratio
ROE
ROA
Currency: USD
Quarterly
Quarterly
Annual
Relevant data have not been disclosed by the company yet.

Income Statement

Revenue
Operating profit
Net Profit
Currency: USD
Quarterly
Quarterly
Annual
Relevant data have not been disclosed by the company yet.

Balance Sheet

Current assets
Total current liabilities
Total assets
Total liabilities
Total equity
Currency: USD
Quarterly
Quarterly
Annual
Relevant data have not been disclosed by the company yet.

Cash Flow Statement

Net operating income
Net investment
Net financing
Currency: USD
Quarterly
Quarterly
Annual
Relevant data have not been disclosed by the company yet.

FAQs

What is the total revenue of Marker Therapeutics Inc?

According to Marker Therapeutics Inc's FY2024 earnings report, its total revenue reached 6.59M, with a year-on-year change of 99.06%.

What is the Earnings Per Share (EPS) of Marker Therapeutics Inc?

According to Marker Therapeutics Inc's FY2024 earnings report, its Earnings Per Share (EPS) was -1.195, with a year-on-year change of -27.81%.

What is the net income of Marker Therapeutics Inc?

According to Marker Therapeutics Inc's FY2024 earnings report, its net income was -10.73M, with a year-on-year change of -30.28%.

What is the net margin of Marker Therapeutics Inc?

According to Marker Therapeutics Inc's FY2024 earnings report, its net profit margin was -162.82%, with a year-on-year change of 61.62%.

What is the gross margin of Marker Therapeutics Inc?

According to Marker Therapeutics Inc's FY2024 earnings report, its gross margin was 100.00%, with a year-on-year change of --.

What is the debt-to-asset ratio of Marker Therapeutics Inc?

According to Marker Therapeutics Inc's FY2024 earnings report, its debt-to-asset ratio was --, with a year-on-year change of --.

What is the Return on Equity (ROE) of Marker Therapeutics Inc?

According to Marker Therapeutics Inc's FY2024 earnings report, its Return on Equity (ROE) was -65.81%, with a year-on-year change of 21.16%.

What is the Return on Assets (ROA) of Marker Therapeutics Inc?

According to Marker Therapeutics Inc's FY2024 earnings report, its Return on Assets (ROA) was -54.82%, with a year-on-year change of -0.60%.

What is the operating profit of Marker Therapeutics Inc?

According to Marker Therapeutics Inc's FY2024 earnings report, its operating profit was -11.12M, with a year-on-year change of 23.75%.

What are the current assets of Marker Therapeutics Inc?

According to Marker Therapeutics Inc's FY2024 earnings report, its current assets were 22.02M, with a year-on-year change of 28.58%.

What are the total assets of Marker Therapeutics Inc?

According to Marker Therapeutics Inc's FY2024 earnings report, its total assets of Marker Therapeutics Inc were 22.02M, with a year-on-year change of 28.58%.

What are the total liabilities of Marker Therapeutics Inc?

According to Marker Therapeutics Inc's FY2024 earnings report, its total liabilities of Marker Therapeutics Inc were 3.46M, with a year-on-year change of 12.67%.

What is the total equity of Marker Therapeutics Inc?

According to Marker Therapeutics Inc's FY2024 earnings report, its total equity of Marker Therapeutics Inc was 18.56M, with a year-on-year change of 32.06%.

What is the net operating income of Marker Therapeutics Inc?

According to Marker Therapeutics Inc's FY2024 earnings report, its net operating income of Marker Therapeutics Inc was -10.73M, with a year-on-year change of 23.60%.

What is the net investment of Marker Therapeutics Inc?

According to Marker Therapeutics Inc's FY2024 earnings report, its net investment of Marker Therapeutics Inc was --, with a year-on-year change of --.

What is the net financing of Marker Therapeutics Inc?

According to Marker Therapeutics Inc's FY2024 earnings report, its net financing of Marker Therapeutics Inc was 14.99M, with a year-on-year change of 1256.54%.
KeyAI